Literature DB >> 20650281

Multiplexing RMCE: versatile extensions of the Flp-recombinase-mediated cassette-exchange technology.

Soeren Turan1, Johannes Kuehle, Axel Schambach, Christopher Baum, Juergen Bode.   

Abstract

There are strong indications, but as yet no proof, that extended 48-bp Flp recombinase targets (FRTs) represent unique targets in all eukaryotic genomes investigated, and that recombinase-mediated cassette exchange is not hampered by the occurrence of genomic pseudo sites. This encouraged the present study in which we explore the feasibility of exchanging, in a given cell, two distinct genomically anchored cassettes, each flanked by a unique set of two heterospecific FRT sites. Mutant FRTs have to meet two major prerequisites for successful recombinase-mediated cassette exchange: (i) a self-recognition capacity comparable to a pair of FRT wild-type sites (FRTxFRT), and (ii) a negligible cross-interaction if part of a set of heterospecific sites (F'xF). We apply a two-step strategy to explore various newly created FRT spacer mutants for these properties. As a result of our screening steps, we identify combinations of sites that are successfully applied to parallel Flp-mediated genomic targeting ("multiplexing") reactions (i.e., the simultaneous exchange of two separate target cassettes in a given cell). Copyright 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20650281     DOI: 10.1016/j.jmb.2010.07.015

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  24 in total

1.  Detection of vulnerable neurons damaged by environmental insults in utero.

Authors:  Masaaki Torii; Masanori Sasaki; Yu-Wen Chang; Seiji Ishii; Stephen G Waxman; Jeffery D Kocsis; Pasko Rakic; Kazue Hashimoto-Torii
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-25       Impact factor: 11.205

2.  Expression of Flp Protein in a Baculovirus/Insect Cell System for Biotechnological Applications.

Authors:  Ida S Jensen; Ken Inui; Srdja Drakulic; Sakthidasan Jayaprakash; Bjoern Sander; Monika M Golas
Journal:  Protein J       Date:  2017-08       Impact factor: 2.371

Review 3.  Protein trap: a new Swiss army knife for geneticists?

Authors:  Svetlana A Fedorova; Natalya V Dorogova
Journal:  Mol Biol Rep       Date:  2019-11-14       Impact factor: 2.316

Review 4.  Rapid prototyping of microbial cell factories via genome-scale engineering.

Authors:  Tong Si; Han Xiao; Huimin Zhao
Journal:  Biotechnol Adv       Date:  2014-11-20       Impact factor: 14.227

Review 5.  Recent advances in mammalian protein production.

Authors:  Ashok D Bandaranayake; Steven C Almo
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

6.  Engineering Inducible Knock-In Mice to Model Oncogenic Brain Tumor Mutations from Endogenous Loci.

Authors:  Jon D Larson; Suzanne J Baker
Journal:  Methods Mol Biol       Date:  2019

7.  Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.

Authors:  Johannes Kuehle; Soeren Turan; Tobias Cantz; Dirk Hoffmann; Julia D Suerth; Tobias Maetzig; Daniela Zychlinski; Christoph Klein; Doris Steinemann; Christopher Baum; Juergen Bode; Axel Schambach
Journal:  Mol Ther       Date:  2014-01-17       Impact factor: 11.454

Review 8.  Accelerating cancer modeling with RNAi and nongermline genetically engineered mouse models.

Authors:  Geulah Livshits; Scott W Lowe
Journal:  Cold Spring Harb Protoc       Date:  2013-11-01

9.  Double conditional human embryonic kidney cell line based on FLP and ΦC31 mediated transgene integration.

Authors:  Christoph Waldner; Olga Rempel; Fabian Schütte; Mert Yanik; Natalie Solomentsew; Gerhart U Ryffel
Journal:  BMC Res Notes       Date:  2011-10-18

10.  Genome engineering in Vibrio cholerae: a feasible approach to address biological issues.

Authors:  Marie-Eve Val; Ole Skovgaard; Magaly Ducos-Galand; Michael J Bland; Didier Mazel
Journal:  PLoS Genet       Date:  2012-01-12       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.